Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.37 |
| ▸ | GJB2 | P29033 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | PYGB | P11216 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31680347 | 0.94 | PYGB (0.35) | PRKCAGJB2MAPK1GBA1PYGB | |
| SCHEMBL31352998 | 0.89 | PYGB (0.39) | GBA1PYGB | |
| SCHEMBL31680331 | 0.89 | PYGB (0.39) | GBA1PYGB | |
| SCHEMBL8067513 | 0.86 | PRKCA (0.42) | PRKCAMAPK1PYGB | |
| SCHEMBL29201539 | 0.81 | PYGB (0.36) | PRKCAGJB2MAPK1PYGB | |
| SCHEMBL28999763 | 0.81 | PYGB (0.36) | PRKCAGJB2MAPK1PYGB | |
| SCHEMBL5247772 | 0.80 | TERT (0.42) | — | |
| SCHEMBL17964544 | 0.80 | TERT (0.42) | — | |
| SCHEMBL28217368 | 0.79 | PYGB (0.34) | PRKCAGJB2MAPK1PYGB | |
| SCHEMBL16394741 | 0.77 | PRKCA (0.41) | PRKCAPYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024186259-A1 | A METHOD FOR ENHANCING RECOMBINANT PRODUCTION IN A PRODUCTION HOST, AN EXPRESSION SYSTEM, A LIBRARY, A PLATFORM SYSTEM, A PRODUCTION STRAIN, AN E. COLI STRAIN, A KIT OF PARTS, A METHOD OF USING THE PLATFORM SYSTEM AND A COMPUTER PROGRAM, RELATED TO THE METHOD | KARYOLAIMOS ALEXANDROS (SE) | 2024-09-12 | — | — | WO | disclosed |
| EP-4419135-A1 | LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE | Vaxdyn S.L. (ES) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023067118-A1 | LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE. | Vaxdyn S.l. (ES) | 2023-04-27 | — | — | WO | disclosed |